Schonfeld Strategic Advisors LLC Kezar Life Sciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.6 - $0.92 $26,640 - $40,848	44,400 New	44,400 $26,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $34,712 - $45,982	15,027 Added 29.31%	66,300 $162,000
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $117,459 - $274,322	-37,527 Reduced 42.26%	51,273 $160,000
Q4 2022 Feb 14, 2023	SELL	$6.39 - $8.8 $235,241 - $323,963	-36,814 Reduced 29.31%	88,800 $625,000
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $398,589 - $536,274	-49,886 Reduced 28.43%	125,614 $1.08 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $508,380 - $1.9 Million	111,000 Added 172.09%	175,500 $1.45 Million
Q1 2022 May 16, 2022	BUY	$12.3 - $18.33 $237,390 - $353,768	19,300 Added 42.7%	64,500 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $336,288 - $755,744	45,200 New	45,200 $756,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.